Privacy settings

We use technical cookies, that are necessary for the management of the website, statistical cookies and marketing cookies (including third parties cookies) for displaying individual offers and ads. For more information read our Privacy Policy. Statistical cookies and marketing cookies (inclusive of third parties cookies) are used only with your consent. By clicking “Select all and agree” you consent to our use of statistical and/or marketing cookies (inclusive of third parties cookies).

To customize your privacy settings, tick your preferences in the checkboxes and click “Apply selection”. You can always change the privacy settings and deactivate cookies by following the instructions in the Privacy Policy.

Show preferences Select all and accept
IMA is loading

Main Financial Data 2000

Main Data: 31/12 Year 2000
Consolidated statement of income (international practice in accordance with IAS/IFRS) Millions/Euro
– total revenues 294.79
– gross margin 137.20
– total operating cost 98.56
– net operating profit 35.37
– financial expenses, net 5.13
– net income before taxes 15.21

 

Consolidated balance sheet Millions/Euro
– operating capital 79.17
– fixed assets, net 100.90
– reserves and MLT non financial payables – 20.83
– net financial position 72.00
– stockholders’ equity 87.24

 

Other information Millions/Euro
– depreciation 12.74
– R & D expenses 17.81

 

  Euro
Dividend per share 0.23

 

  No.
Employees 2,121

 

  Lire
Shares outstanding 36,100,000,000

 

Main Data: 30/06 Year 2000
Consolidated statement of income (international practice in accordance with IAS/IFRS) Millions/Euro
– total revenues 105.21
– gross margin 51.19
– total operating cost 50.56
– net operating profit 0.89
– financial expenses, net 2.22
– net income before taxes – 1.66

 

Consolidated balance sheet Millions/Euro
– operating capital 92.42
– fixed assets, net 89.44
– reserves and MLT non financial payables – 20.37
– net financial position – 91.33
– stockholders’ equity 70.15

 

Other information Millions/Euro
– depreciation 5.80
– R & D expenses 9.64

 

  No.
Employees 2,079

 

  Lire
Shares outstanding 36,100,000,000

 

Net Sales by Sector: Year 2000
  Millions/Euro  
tea, herbs & coffee 46.87 15.90%
pharmaceuticals packaging 238.49 80.90%
pharmaceuticals processing 9.43 3.20%
Total 294.79 100.00%

 

Net Sales by Country: Year 2000  
  Millions/Euro  
E.U. (excluding Italy) 96.16 32.62%
Other European countries 26.40 8.90%
North America 56.48 19.16%
Asia & Middle East 41.37 14.03%
Other countries 54.60 18.52%
Total exports 274.85 93.23%
Italy 19.95 6.77%
Total 294.80 100.00%